These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 27333752)

  • 1. [Management of dyslipidemia for stroke prevention from the perspective of J-STARS].
    Hosomi N; Matsumoto M
    Nihon Rinsho; 2016 Apr; 74(4):634-40. PubMed ID: 27333752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid-lowering drugs in ischemic stroke prevention and their influence on acute stroke outcome.
    Fuentes B; Martínez-Sánchez P; Díez-Tejedor E
    Cerebrovasc Dis; 2009; 27 Suppl 1():126-33. PubMed ID: 19342842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current status of statin therapy for stroke prevention.
    Sett AK; Robinson TG; Mistri AK
    Expert Rev Cardiovasc Ther; 2011 Oct; 9(10):1305-14. PubMed ID: 21985543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pravastatin Reduces the Risk of Atherothrombotic Stroke when Administered within Six Months of an Initial Stroke Event.
    Hosomi N; Nagai Y; Kitagawa K; Nakagawa Y; Aoki S; Nezu T; Kagimura T; Maruyama H; Origasa H; Minematsu K; Uchiyama S; Matsumoto M;
    J Atheroscler Thromb; 2018 Mar; 25(3):262-268. PubMed ID: 28924103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [J-STARS (Japan statin treatment against recurrent stroke)].
    Kohriyama T; Nomura E; Matsumoto M; Ohtsuki T
    Nihon Rinsho; 2006 Oct; 64 Suppl 7():511-8. PubMed ID: 17461197
    [No Abstract]   [Full Text] [Related]  

  • 7. More than half of stroke patients were not given preventive drugs, study finds.
    Mayor S
    BMJ; 2016 Nov; 355():i6105. PubMed ID: 27852578
    [No Abstract]   [Full Text] [Related]  

  • 8. Dyslipidemia as a risk factor for ischemic stroke.
    Tziomalos K; Athyros VG; Karagiannis A; Mikhailidis DP
    Curr Top Med Chem; 2009; 9(14):1291-7. PubMed ID: 19849661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials.
    Jones PH; Cusi K; Davidson MH; Kelly MT; Setze CM; Thakker K; Sleep DJ; Stolzenbach JC
    Am J Cardiovasc Drugs; 2010; 10(2):73-84. PubMed ID: 20136164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical practice guidelines for the management of dyslipidemia in chronic kidney disease].
    Shoji T
    Nihon Jinzo Gakkai Shi; 2013; 55(7):1267-75. PubMed ID: 24288962
    [No Abstract]   [Full Text] [Related]  

  • 11. Do persons with stroke benefit from statin-fibrate combination therapy?
    Castilla-Guerra L; Fernandez-Moreno Mdel C
    Eur J Intern Med; 2015 Mar; 26(2):148-9. PubMed ID: 25620642
    [No Abstract]   [Full Text] [Related]  

  • 12. Are the ACC/AHA guidelines on the treatment of blood cholesterol a game changer? A perspective from the Canadian Cardiovascular Society Dyslipidemia Panel.
    Anderson TJ; Grégoire J; Hegele RA; Couture P; Mancini GB; McPherson R; Francis GA; Poirier P; Lau DC; Grover S; Genest J; Carpentier AC; Dufour R; Gupta M; Ward R; Leiter LA; Lonn E; Ng DS; Pearson GJ; Yates GM; Stone JA; Ur E
    Can J Cardiol; 2014 Apr; 30(4):377-80. PubMed ID: 24589194
    [No Abstract]   [Full Text] [Related]  

  • 13. Treating dyslipidemia in the high-risk patient.
    Jones PH
    J Fam Pract; 2010 Feb; 59(2):E1. PubMed ID: 20141719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy and adverse effects of the addition of ezetimibe to statin versus statin titration in chronic kidney disease patients.
    Suzuki H; Watanabe Y; Kumagai H; Shuto H
    Ther Adv Cardiovasc Dis; 2013 Dec; 7(6):306-15. PubMed ID: 24280596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology position statement on dyslipidemia management. Differences between the European and American guidelines].
    Lobos Bejarano JM; Galve E; Royo-Bordonada MÁ; Alegría Ezquerra E; Armario P; Brotons Cuixart C; Camafort Babkowski M; Cordero Fort A; Maiques Galán A; Mantilla Morató T; Pérez Pérez A; Pedro-Botet J; Villar Álvarez F; González-Juanatey JR;
    Clin Investig Arterioscler; 2015; 27(1):36-44. PubMed ID: 25444651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Japanese Guidelines for the Management of Stroke 2009 : important revised points necessary for the neurologist].
    Shinohara Y
    Rinsho Shinkeigaku; 2010 Nov; 50(11):808-11. PubMed ID: 21921447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recommendations for management of dyslipidemia in 2016 in Switzerland].
    Aubert CE; Gencer B; Rodondi N
    Rev Med Suisse; 2016 Mar; 12(508):430-4. PubMed ID: 27089598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the statin escape phenomenon on long-term clinical outcomes in patients with acute myocardial infarction: Subgroup analysis of the Nagoya Acute Myocardial Infarction Study (NAMIS).
    Ota T; Ishii H; Suzuki S; Shibata Y; Tatami Y; Harata S; Shimbo Y; Takayama Y; Tanaka A; Kawamura Y; Osugi N; Maeda K; Kondo T; Murohara T
    Atherosclerosis; 2015 Sep; 242(1):155-60. PubMed ID: 26188539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fenofibric acid: in combination therapy in the treatment of mixed dyslipidemia.
    Yang LP; Keating GM
    Am J Cardiovasc Drugs; 2009; 9(6):401-9. PubMed ID: 19929038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk reductions for cardiovascular disease with pravastatin treatment by dyslipidemia phenotype: a post hoc analysis of the MEGA Study.
    Nishiwaki M; Ikewaki K; Ayaori M; Mizuno K; Ohashi Y; Ohsuzu F; Ishikawa T; Nakamura H;
    J Cardiol; 2013 Mar; 61(3):196-200. PubMed ID: 23265677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.